Sort by
Keyphrases
Subcutaneous Injection
100%
Photosystem II
100%
Pentosan Polysulfate
100%
Glycosaminoglycans
85%
Cerebrospinal Fluid
28%
Adverse Effects
14%
Inflammation
14%
Therapeutic Benefits
14%
Clinically Significant
14%
Aorta
14%
Safety Impact
14%
Inflammatory Cytokines
14%
Tumor Necrosis Factor-α
14%
Rat Model
14%
Interleukin-8
14%
Treatment Group
14%
Spine
14%
Therapeutic Effect
14%
Long-term Safety
14%
Carotid Artery
14%
Elastin
14%
Drug Dependence
14%
Aorta Artery
14%
Clusterin
14%
Liver Enzymes
14%
Aortic Inflammation
14%
Skeletal Phenotype
14%
Inflammation Regulation
14%
Large Animal Model
14%
Coagulation Factors
14%
MPS VI
14%
Human Equivalent Dose
14%
Vessel Integrity
14%
Safety Parameters
14%
Storage Reduction
14%
Cytokine Reduction
14%
Storage Vacuoles
14%
Pharmacology, Toxicology and Pharmaceutical Science
Subcutaneous Injection
100%
Pentosan Polysulfate
100%
Hurler Syndrome
100%
Glycosaminoglycan
85%
Mucopolysaccharidosis
57%
Inflammation
42%
Cytokine
42%
Tumor Necrosis Factor
14%
Rat Model
14%
Therapeutic Effect
14%
Clusterin
14%
Liver Enzyme
14%
Blood Clotting Factor
14%
Maroteaux Lamy Syndrome
14%
Elastin
14%
Treatment Group
14%
Immunology and Microbiology
Cytokine
100%
Cerebrospinal Fluid
100%
Rat Model
50%
Proinflammatory Cytokine
50%
Tumor Necrosis Factor Alpha
50%
Carotid Artery
50%
Vertebral Column
50%
Interleukin 8
50%
Veterinary Science and Veterinary Medicine
Dog
100%
Pentosan Polysulfate
100%
Glycosaminoglycan
85%
Inflammation
42%
Cerebrospinal Fluid
28%
Rat
14%
Vertebral Column
14%
Carotid Artery
14%
Vacuolization
14%
Histopathology
14%